Answers are grounded in this paper and cite their sources.
Clinical characterization reveals molecular diagnosis in 46% of individuals with 46,XY DSD, suggesting targeted interventions could improve outcomes.
Sanger sequencing followed by NGS could provide molecular diagnosis in 46% of this Indian cohort with 46,XY DSD. SRD5A2, AR and NR5A1 were the most frequently implicated genes.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: